Navigation Links
Novel experiment documents evolution of genome in near-real time

tes the process of enzymatically breaking down glycerol. Cells with mutations in the so-called glycerol kinase gene grew 20 to 60 percent faster than those without the mutation.

Mutations also appeared in a second, unrelated gene for an enzyme called RNA polymerase. "That was a surprise to almost everybody because RNA polymerase is involved in one of the core processes of any cell," said Palsson. "You wouldn't expect that gene to change because a wide variety of cellular process would be affected; it's like replacing the wiring system in a building when a light bulb burns out. But we repeated the experiment more than 50 times and mutations in the RNA polymerase gene appeared again and again."

The researchers report that mutations in both genes appeared together in several cases after six to eight days in the glycerol-based cultures, and E. coli cells containing both mutated genes grew 150 percent faster than the starting strain of E. coli. To confirm that the mutants were indeed responsible for the faster growth, the researchers substituted the two mutant genes into the original strain and duplicated the faster growth rate. "We expected to find many mutated genes and we thought our results would be very difficult to understand, but neither was the case," said Christopher D. Herring, a co-author of the paper and a former member of Palsson's team who is now a research scientist at Mascoma Corp. in Lebanon, NH.

All the mutants arose in the experiments presumably as the result of naturally occurring errors in copying DNA into daughter cells during cell division. The precise changes in the sequence of DNA subunits were determined with comparative genomic sequencing technology from NimbleGen Systems, and further analyzed with technology from Sequenom Inc., a San Diego-based biotech company.

"This straightforward approach to the study of experimental evolution can be used as a tool for discovery and analysis, and could even be used to d
'"/>

Source:University of California - San Diego


Page: 1 2 3

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. Novel Enzyme Shows Potential As An Anti-HIV Target
5. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
6. Discovery Could Lead To Novel Approaches In HIV Treatment
7. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
8. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
9. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
10. Novel live reporting system to track cells
11. Field of beams - Novel system uses polarized light pulses to reveal crop health
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Novel experiment documents evolution genome near real time

(Date:4/13/2015)... a leading cloud-based consumer engagement platform that provides trusted ... communities around health and wellness, announced today the launching ... The ... vehicle to receive validated health information from consumers. ... will allow higi,s trusted partners, on a user opt-in ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... 2, 2015 At its 2015 ACMG Annual ... , the American College of Medical Genetics and ... to its Board.  Members of the ACMG Board of ... forming and advancing its policies and programs. ACMG is ... "It,s an eventful time in medical genetics and ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... F.L. MARCH 27, 2009 The founder of a ... genetic tests in making medical decisions is the 2009 ... for lifetime achievement in the field of genetic sciences. ... the University of Washington School of Medicine in Seattle, ...
... Scripps Research Institute has obtained the first glimpse of a ... cells. The protein, called P-glycoprotein or P-gp for short, is ... chemotherapy drugs. Understanding its structure may help scientists design more ... March 27, 2009, issue of the journal Science . ...
... new drug developed at the University of California, Davis ... II of human clinical trials to evaluate its efficacy. ... (s-EH) inhibitor, is "a first-in-class drug which may treat ... entomologist Bruce Hammock, who with UC Berkeley cell biologist ...
Cached Biology News:Roberta A. Pagon receives lifetime award in genetics from March of Dimes 2Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy 2Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 2UC Davis bench-to-bedside research: Promising treatment in clinical trials 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 4UC Davis bench-to-bedside research: Promising treatment in clinical trials 5
(Date:5/5/2015)... , May 5, 2015  Tikcro Technologies ... was approved to continue trading on OTCQB  Marketplace, ... OTCQB Marketplace allows for a continuous public ... Investors can have real-time quotes and market information ... The OTCQB Marketplace includes U.S. and international ...
(Date:5/5/2015)... SAN DIEGO , May 5, 2015  A ... the formation of the Coma Research Institute, a non-profit ... to patients and families suffering from disorders of consciousness.  ... Logo - http://photos.prnewswire.com/prnh/20150504/213779LOGO   ... severe disorder of consciousness, in which no voluntary actions ...
(Date:5/5/2015)... SAN FRANCISCO, Calif. , May 5, 2015 /PRNewswire/ ... the treatment of cancer, today announced that Sean ... at the Credit Suisse Antibody Day in ... Wednesday, May 6. Dr. McCarthy will present an overview ... immunotherapy and Probody drug conjugate programs. About ...
(Date:5/5/2015)... 5, 2015  Indianapolis-based medical device manufacturer NICO ... line of products including the BrainPath® and Myriad™ ... deep-seated brain abnormalities and then removing affected tissue. ... more than 50 institutions throughout the ... been included in 12 abstracts, three peer-reviewed publications, ...
Breaking Biology Technology:Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 3Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 4Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 5NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 2NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 3
... (Nasdaq: QGLY ) today reported net sales from ... June 30, 2008,compared to $2.2 million reported for the ... ended June 30, 2008, net sales were $7.4 million,compared ... June 30, 2007., 2008 net sales were influenced ...
... have devised a way to squeeze light into tighter ... new technology in the fields of optical communications, miniature ... in passing light through gaps 200 nanometers wide, about ... hair. A group of UC Berkeley researchers led by ...
... July 30 /Xinhua-PRNewswire-FirstCall/ -- China,Biologic Products, Inc. (OTC ... the leading plasma-based pharmaceutical companies in the,People,s Republic ... 2008, it has appointed Mr. Sean Shao, Dr. ... independent members of its Board of Directors, and ...
Cached Biology Technology:The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 2The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 3The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 4The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 5The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 6New technique to compress light could open doors for optical communications 2New technique to compress light could open doors for optical communications 3China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 2China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 3China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 4
... Single-cell and patch delivery Removable / ... Very small dead volume , Vacuum ... 250 and 100 micron delivery tips - removable ... Available in 4, 8, and 16 channels. Specify ...
Sf21 cells derived from Spodoptera frugiperda ovarian cells are recommended for high-level production of recombinant proteins. Higher expression levels of some proteins are seen due to the larger ce...
... the most comprehensive, cost-effective solution to ... incorporated unprecedented quality into both our ... proven detection chemistries and antibodies that ... protocol. It also includes our competitively ...
Functionally tested for consistent G-banding of chromosomes....
Biology Products: